Krilogy Financial LLC Fibrogen Inc Transaction History

Krilogy Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 15, 2018	SELL	$44.9 - $64.95 $8,980 - $12,990	-200 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$45.35 - $61.65 $4,535 - $6,165	100 Added 100.0%	200 $9,000
Q3 2017 Nov 15, 2017	SELL	$33.4 - $53.9 $3,340 - $5,390	-100 Reduced 50.0%	100 $5,000
Q2 2017 Aug 15, 2017	BUY	N/A	200	200 $6,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $46.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.